Disseminated Sporothix schenckii in a patient with AIDS

Journal of Infection

Volumn 51, Issue 3, 2005, Pages

  Hardman, Susan ^a   Stephenson, I ^a   Jenkins, D R ^a   Wiselka, M J ^a   Johnson, E M ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

HIV; Meningitis; Sporothrix schenckii

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CEFTRIAXONE; DEXAMETHASONE; ETHAMBUTOL; FLUCONAZOLE; FLUCYTOSINE; ISONIAZID; ITRACONAZOLE; PYRAZINAMIDE; RIFAMPICIN; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CONFUSION; DROWSINESS; FEVER; FUNGAL MENINGITIS; FUNGUS CULTURE; FUNGUS GROWTH; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROCEPHALUS; MALE; MENINGOENCEPHALITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SKIN BIOPSY; SKIN DEFECT; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE; UNITED KINGDOM;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DERMATOMYCOSES; FATAL OUTCOME; HIV INFECTIONS; HIV-1; HUMANS; MALE; MENINGITIS, FUNGAL; SPOROTHRIX; SPOROTRICHOSIS;

EID: 27644524729     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.07.001     Document Type: Article

References (14)

1. National Committee for Clinical Laboratory Standards (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard M38-A. NCCLS, Wayne, PA.
2. Sporothrix schenckii, In: G.L. Mandell J.E. Bennett R. Dolin, editors. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases 5th edn 2000 Churchill Livingstone London pp. 2695-2699
3. C.C. Penn E. Goldstein W.R. Bartholemew Sporothrix schenckii meningitis in a patient with AIDS Clin Infect Dis 15 4 1992 741-3
4. H. Donabedian E. O'Donnell C. Olszewski R.D. MacArthur N. Budd Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient Diagn Microbiol Infect Dis 18 2 1994 111-5
5. L.D. Rotz L.N. Slater M.F. Wack A.L. Boyd E.N. Scott R.A. Greenfield Disseminated sporotrichosis with meningitis in a patient with AIDS Infect Dis Clin Pract 5 1996 566-8
6. J.A. Al-Tawfiq K.K. Wools Disseminated sporotrichosis and Sporothrix schenckii fungaemia as initial presentation of human immunodeficiency virus infection Clin Infect Dis 26 6 1998 1403-6
7. F. Bolao D. Podzamczer M. Ventin F. Gudiol Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis Eur J Clin Microbiol Infect Dis 13 1994 609-12
8. A. Bonifaz A. Peniche P. Mercadillo A. Saul Successful treatment of AIDS-related disseminated cutaneous sporotrichosis with itraconazole AIDS Patient Care STDS 15 12 2001 603-6
9. J. Neto Rda A.A. Machado G. de Castro A.S. Quaglio R. Martinez Disseminated cutaneous sporotrichosis as the initial manifestation of the acquired immunodeficiency syndrome-case report Rev Soc Bras Med Trop 32 1 1999 57-61
10. A.J. Ware C.J. Cockerell D.J. Skiest H.M. Kussman Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS J Am Acad Dermatol 40 2 Pt 2 1999 350-5
11. C.A. Kauffman R. Hajjeh S.W. Chapman Practice guidelines for the management of patients with sporotrichosis Clin Infect Dis 30 4 2000 684-7
12. J.H. Baker H.C. Goodpasture H.R. Kuhns et al. Fungaemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii: Successful treatment with itraconazole Arch Pathol Lab Med 113 1989 1279-81
13. A. Vermes H.-J. Guchelaar J. Dankert Flucytosine: A review of its pharmacology, clinical interactions, pharmacokinetics, toxicity and drug interactions J Antimicrob Chemother 46 2000 171-9
14. E.N. Scott L. Kaufman A.C. Brown H.G. Muchmore Serologic studies in the diagnosis and management of meningitis due to Sporothrix schenckii N Engl J Med 317 15 1987 935-40